The dark side of centromeres: types, causes and consequences of structural abnormalities implicating centromeric DNA

V Barra, D Fachinetti - Nature Communications, 2018 - nature.com
Centromeres are the chromosomal domains required to ensure faithful transmission of the
genome during cell division. They have a central role in preventing aneuploidy, by …

Chromosome abnormalities: new insights into their clinical significance in cancer

F Kou, L Wu, X Ren, L Yang - Molecular Therapy-Oncolytics, 2020 - cell.com
Chromosomal abnormalities, consisting of numerical and structural chromosome
abnormalities, are a common characteristic of cancer. Numerical chromosome …

Identification of the copy number variant biomarkers for breast cancer subtypes

X Pan, XH Hu, YH Zhang, L Chen, LC Zhu… - Molecular Genetics and …, 2019 - Springer
Breast cancer is a common and threatening malignant disease with multiple biological and
clinical subtypes. It can be categorized into subtypes of luminal A, luminal B, Her2 positive …

Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling

J Jiang, C Yu, M Chen, S Tian, C Sun - Biochemical and biophysical …, 2015 - Elsevier
Hepatocellular carcinoma (HCC) is the most common cancer in the world especially in East
Asia and Africa. Advanced stage, metastasis and frequent relapse are responsible for the …

The molecular genetic make-up of male breast cancer

CB Moelans, J de Ligt, P van der Groep… - Endocrine-related …, 2019 - erc.bioscientifica.com
Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast
malignancies. Therefore, clinical management of MBC is currently guided by research on …

[HTML][HTML] Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology

V Valentini, V Silvestri, A Bucalo, G Conti… - Frontiers in …, 2023 - frontiersin.org
Introduction Compared with breast cancer (BC) in women, BC in men is a rare disease with
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …

p53 and miR‐210 regulated NeuroD2, a neuronal basic helix–loop–helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor …

R Agrawal, A Garg, P Benny Malgulwar… - … Journal of Cancer, 2018 - Wiley Online Library
The factors involved in cell differentiation have recently garnered interest for their role in
inhibition of pathogenesis in various tumors. However, their role in glioblastoma (GBM) …

A Retrospective View of the Triple-Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components Using …

M Kim, W Yang, D Hong, HS Won, S Yoon - Cancers, 2024 - mdpi.com
Simple Summary Triple-negative breast cancer (TNBC) comprises about 15% of all breast
cancers worldwide and is known to have a poorer prognosis compared to other subtypes of …

Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer

A Madrid-Paredes, M Canadas-Garre… - Breast cancer research …, 2015 - Springer
HER2 receptor is overexpressed approximately in 20% of human breast cancer (BC) and is
a poor prognostic factor. Although therapies targeting this receptor have improved the …

Grb7 protein RA domain oligomerization

MP Godamudunage, A Foster… - Journal of Molecular …, 2017 - Wiley Online Library
The growth factor receptor bound protein 7 (Grb7) is an adaptor protein that is often
coamplified with the erythroblastosis oncogene B 2 receptor in 20% to 30% of breast cancer …